CYTK vs. SMH
Compare and contrast key facts about Cytokinetics, Incorporated (CYTK) and VanEck Vectors Semiconductor ETF (SMH).
SMH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Semiconductor 25 Index. It was launched on Dec 20, 2011.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CYTK or SMH.
Correlation
The correlation between CYTK and SMH is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CYTK vs. SMH - Performance Comparison
Key characteristics
CYTK:
-0.88
SMH:
-0.27
CYTK:
-1.21
SMH:
-0.11
CYTK:
0.85
SMH:
0.99
CYTK:
-0.63
SMH:
-0.33
CYTK:
-1.68
SMH:
-0.84
CYTK:
25.39%
SMH:
13.95%
CYTK:
48.86%
SMH:
42.89%
CYTK:
-97.09%
SMH:
-83.29%
CYTK:
-63.46%
SMH:
-31.25%
Returns By Period
In the year-to-date period, CYTK achieves a -16.07% return, which is significantly higher than SMH's -20.50% return. Over the past 10 years, CYTK has underperformed SMH with an annualized return of 18.31%, while SMH has yielded a comparatively higher 22.64% annualized return.
CYTK
-16.07%
-9.14%
-28.18%
-41.07%
21.04%
18.31%
SMH
-20.50%
-15.34%
-23.11%
-7.31%
24.77%
22.64%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CYTK vs. SMH — Risk-Adjusted Performance Rank
CYTK
SMH
CYTK vs. SMH - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Cytokinetics, Incorporated (CYTK) and VanEck Vectors Semiconductor ETF (SMH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CYTK vs. SMH - Dividend Comparison
CYTK has not paid dividends to shareholders, while SMH's dividend yield for the trailing twelve months is around 0.56%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CYTK Cytokinetics, Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SMH VanEck Vectors Semiconductor ETF | 0.56% | 0.44% | 0.60% | 1.18% | 0.51% | 0.69% | 1.50% | 1.88% | 1.43% | 0.80% | 2.14% | 1.16% |
Drawdowns
CYTK vs. SMH - Drawdown Comparison
The maximum CYTK drawdown since its inception was -97.09%, which is greater than SMH's maximum drawdown of -83.29%. Use the drawdown chart below to compare losses from any high point for CYTK and SMH. For additional features, visit the drawdowns tool.
Volatility
CYTK vs. SMH - Volatility Comparison
The current volatility for Cytokinetics, Incorporated (CYTK) is 20.23%, while VanEck Vectors Semiconductor ETF (SMH) has a volatility of 22.97%. This indicates that CYTK experiences smaller price fluctuations and is considered to be less risky than SMH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.